NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Símbolo de cotizaciónNIVF
Nombre de la empresaNewGenIvf Group Ltd
Fecha de salida a bolsaFeb 15, 2022
Director ejecutivoMr. Claudius Tsang
Número de empleados76
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 15
DirecciónLevel 39, Marina Bay Financial Centre
Ciudad
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísSingapore
Código postal018983
Teléfono6568185796
Sitio Webhttps://newgenivf.com/
Símbolo de cotizaciónNIVF
Fecha de salida a bolsaFeb 15, 2022
Director ejecutivoMr. Claudius Tsang
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos